RUSSO, Diego
 Distribuzione geografica
Continente #
NA - Nord America 6.852
AS - Asia 5.036
EU - Europa 1.599
SA - Sud America 1.197
AF - Africa 109
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.810
Nazione #
US - Stati Uniti d'America 6.592
SG - Singapore 2.359
CN - Cina 1.220
BR - Brasile 926
IT - Italia 673
VN - Vietnam 592
IN - India 476
SE - Svezia 292
GB - Regno Unito 190
DE - Germania 172
CA - Canada 164
AR - Argentina 109
HK - Hong Kong 63
BD - Bangladesh 59
FI - Finlandia 59
EC - Ecuador 57
MX - Messico 57
TR - Turchia 56
ID - Indonesia 40
IQ - Iraq 30
RU - Federazione Russa 30
ZA - Sudafrica 28
UA - Ucraina 25
ES - Italia 24
NL - Olanda 24
CO - Colombia 22
PY - Paraguay 22
IR - Iran 18
PK - Pakistan 18
PL - Polonia 17
CL - Cile 16
JP - Giappone 16
MA - Marocco 16
RO - Romania 15
VE - Venezuela 15
FR - Francia 14
DZ - Algeria 13
EE - Estonia 13
UY - Uruguay 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
PE - Perù 11
DO - Repubblica Dominicana 10
KE - Kenya 10
IE - Irlanda 9
JM - Giamaica 9
TN - Tunisia 9
ET - Etiopia 8
SA - Arabia Saudita 8
BO - Bolivia 7
GR - Grecia 7
JO - Giordania 7
AU - Australia 6
IL - Israele 6
KR - Corea 6
AT - Austria 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BE - Belgio 4
HN - Honduras 4
SV - El Salvador 4
BG - Bulgaria 3
BH - Bahrain 3
DK - Danimarca 3
EU - Europa 3
GT - Guatemala 3
HR - Croazia 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BY - Bielorussia 1
GN - Guinea 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MG - Madagascar 1
MN - Mongolia 1
MY - Malesia 1
Totale 14.800
Città #
San Jose 1.094
Chandler 778
Dallas 662
Singapore 589
Ashburn 582
Santa Clara 417
Hefei 373
Bengaluru 372
Princeton 360
Lawrence 359
Milan 352
Ho Chi Minh City 220
Wilmington 197
Chicago 151
London 145
Beijing 141
Hanoi 121
Munich 120
Ottawa 119
Des Moines 118
São Paulo 76
Boardman 66
Hong Kong 62
Shanghai 58
Los Angeles 48
Turku 46
Council Bluffs 43
Catanzaro 42
Haiphong 38
Norwalk 37
Rio de Janeiro 33
Guangzhou 29
New York 29
Da Nang 28
Shenzhen 25
Brooklyn 23
Redwood City 22
Pune 21
Chennai 20
Rome 20
Guayaquil 19
Curitiba 18
Quito 18
Thái Bình 18
Hanover 17
Istanbul 17
Mexico City 17
San Francisco 17
Brasília 15
Jiaxing 15
Montreal 15
Belo Horizonte 14
Ninh Bình 14
Porto Alegre 14
Seattle 14
Washington 14
Ankara 13
Atlanta 13
Campinas 13
Johannesburg 13
Biên Hòa 12
Orem 12
Redmond 12
Baghdad 11
Delhi 11
Helsinki 11
Manaus 11
Phoenix 11
Salvador 11
Tokyo 11
Warsaw 11
Boston 10
Dhaka 10
Horia 10
Montevideo 10
Stockholm 10
Toronto 10
Ann Arbor 9
Buffalo 9
Fortaleza 9
Hortolândia 9
Hải Dương 9
Jakarta 9
Nairobi 9
Quanzhou 9
Tashkent 9
Xi'an 9
Abu Dhabi 8
Bauru 8
Buenos Aires 8
Guarulhos 8
Nottingham 8
Ribeirão Preto 8
Rui'an 8
Santo André 8
The Dalles 8
Voghera 8
Wuhan 8
Wuxi 8
Casablanca 7
Totale 8.721
Nome #
Biological Activity of Oleuropein and Its Derivatives 182
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer 90
Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells 87
Anti-hTERT siRNA-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 86
Precision oncology for RET-related tumors 85
A case of metastatic medullary thyroid carcinoma: early identification before surgery of a ret proto-oncogene somatic mutation in fine needle aspirate specimen 85
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases 81
A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC 80
Antiproliferative effects afforded by pyrazolopyrimidine derivates on human neuroblastoma cells 80
Impact of legumes and plant proteins consumption on cognitive performances in the elderly 80
A novel mutation in the thyrotropin receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistence to TSH 79
Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells 79
IL-20 Subfamily Biological Effects: Mechanistic Insights and Therapeutic Perspectives in Cancer 78
Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells 78
Hashimoto's thyroiditis and vestibular dysfunction 77
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy 77
A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation 77
A Phe 486 TSH receptor mutation in a autonomously functioning follicular carcinoma that was causing hyperthyroidism 75
A thyroid follicular cancer presenting as a hot nodule and hyperfunctioning because of an activating mutation of the TSH receptor 75
Absence od Sodium/Iodide symporter gene mutations in differentiated human thyroid carcinomas 74
A novel mutation in the Thyrotropin receptor gene causing loss of TSH binding but constitutive activation in a family with resistance to TSH 74
Anti-hTERT siRNA nanoparticles block the growth of anaplastic thyroid cancer cells in vitro and in vivo. 74
A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH 74
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 73
Antiproliferative and antioxidant effects of oleuropein and its semisynthetic peracetylated derivatives on breast cancer cells 73
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor 73
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis 73
Association between low C-peptide and fragility fractures in postmenopausal women without diabetes 72
Antiproliferative activity of PDE5 inhibitors vehicled by nanovescicles in thyroid cancer cells. 70
Activating mutations of the TSH Receptor in differentiated thyroid carcinomas 68
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization 68
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis 67
A case of metastatic medullary thyroid carcinoma: Early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens 67
TSH-CONJUGATED NANOCARRIER FOR THE TREATMENT OF THYROID CANCER 66
Adenyl cyclase activity and Gs and Gi alpha ADP-ribosylation in thyroid hyperfunctioning adenomas presenting TSH receptor or Gsp mutations 65
Antiproliferative Effects of Two Pyrazolo-Pyrimidine Derivates on Human Anaplastic Thyroid Cancer Cells 65
Antiproliferative activity of PDE5 inhibitors vehicled by nanovesicles in thyroid cancer cells 64
Antioxidant and antiproliferative effects of olive-leaf extract oleuropein and its peracetylated derivate on human thyroid cancer cells 64
Expression and cellular localization of Ref-1 in human thyroid carcinoma cell lines 63
Evaluation of biological effects of TERT inhibition in human thyroid cancer cells 63
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma. 63
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 62
Absence of iodide symporter gene mutations in human thyroid tumors 62
Epigenetic-related gene expression profile in Medullary Thyroid Cancer revealed the overexpression of the Histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 62
Antiproliferative activity of PDE5 inhibitors vehicle by nanovesicles in thyroid cancer cells. 62
A new structural model for the Thyrotropin receptor as determined by covalent crosslinking of Thyrotropin to the recombinant receptor in intact cells: evidence for a single polypeptide chain. 61
Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice 61
A call to action: Now is the time to screen elderly and treat osteosarcopenia, a position paper of the italian college of academic nutritionists med/49 (ican-49) 61
Carcinomi differenziati della tiroide: ruolo oncogenico del recettore del TSH 60
Antiproliferative effects of olive-leaf extract oleuropein and derivatives in human breast cancer cells 59
A novel germline VHL gene mutation in two different patients with pheochromocytoma. 58
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis 57
Analisi della proteina APE/Ref-1 nei noduli tiroidei iperfunzionanti: aumento dell’espressione nelle frazioni nucleari 57
NANOVETTORE CONIUGATO CON TSH PER IL TRATTAMENTO DEL CANCRO DELLA TIROIDE 56
Vestibular disorders in euthyroid patients with Hashimoto’s thyroiditis: role of thyroid autoimmunity. 56
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfunctioning nodules 56
Functional analysis of the cytoplasmic domains of the human TSH receptor by site-directed mutagenesis. 55
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 55
Ape1/Ref-1 is increased in nuclear fractions of human thyroid hot nodules 54
Functional interaction among thyroid specific transcription factors: PAX8 regulates the activity of Hex promoter 54
MicroRNAs as Biomarkers in Thyroid Carcinoma 54
Genetic analysis in fine needle aspiration of the thyroid: a new tool for clinic 54
Oleacein inhibits STAT3, activates the apoptotic machinery, and exerts anti-metastatic effects in the SH-SY5Y human neuroblastoma cells 54
Maggisano V., Capriglione F., Mio C., Bulotta S., Damante G., Russo D., Celano M 53
Expression and localization of the sodium/iodide symporter (NIS) in testicular cells 53
Alterazioni del trasportatore dello iodio in patologia tiroidea 53
An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma 53
Expression of adenylyl cyclase types III and VI in human hyperfunctioning thyroid nodules 53
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer. 53
Carcinoma midollare della tiroide: identificazione di una nuova mutazione 53
Expression of YAP1 in aggressive thyroid cancer 53
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAFV600E mutation 52
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 52
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches. 51
Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. 51
Control of PTEN gene expression in normal and neoplastic thyroid cells 51
Expression of leptin receptor and effects of leptin on papillary thyroid carcinoma cells 51
Normocaloric Diet Restores Weight Gain and Insulin Sensitivity in Obese Mice 51
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes. 51
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 51
Safety Evaluation of Subchronic Oral Administration of Oleuropein and its Semisynthetic Peracetylated Derivative 51
Dihydrotanshinone exerts antitumor effects and improves the effects of cisplatin in anaplastic thyroid cancer cells 51
Identification of thyroid-associated serum microrna profiles and their potential use in thyroid cancer follow-up 50
Genetica molecolare delle tireopatie 50
Aqueous–core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response 50
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency. 50
Co-Encapsulation of Paclitaxel and JQ1 in Zein Nanoparticles as Potential Innovative Nanomedicine 49
Absence of Sodium-Iodide Symporter gene mutations in differentiated human thyroid carcinomas 49
Different molecular mechanisms are involved in the multihormonal control of glucose transport in FRTL-5 rat thyroid cells 49
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfuctioning nodules 49
Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in Obesity 49
Analysis of YAP1 expression in papillary thyroid cancer, lymph node metastases and medullary thyroid cancer. 49
Detection of an activating mutation of the TSH receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 49
Genetic analysis in fine needle aspiration biopsy of the thyroid: a new tool for the clinic. 49
Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells. 49
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells 48
Correlazione genotipo/fenotipo negli adenomi autonomi iperfunzionanti della tiroide con e senza mutazioni nella proteina Gs alfa o nel recettore del TSH 48
A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism 48
Iodide symporter gene expression in normal and transformed rat thyroid cells 48
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells 48
Totale 6.282
Categoria #
all - tutte 156.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 7 11 33
2021/2022873 4 3 7 185 117 11 37 210 80 59 147 13
2022/20232.398 738 98 73 186 246 204 5 174 351 135 146 42
2023/2024834 164 142 57 43 49 229 13 36 16 17 12 56
2024/20253.321 551 316 155 180 123 415 24 87 450 286 227 507
2025/20267.026 243 925 961 1.549 686 222 837 503 830 270 0 0
Totale 14.990